Analyst Price Targets — SLE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 14, 2024 8:17 am | Jack Vander Aarde | Maxim Group | $36.00 | $11.37 | StreetInsider | Super League Gaming (SLE) PT Lowered to $3 at Maxim Group |
Latest News for SLE
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, multicenter study investigating the combination of LUPKYNISÂ
Johnson and Johnson presents new IMAAVYÂ (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained dise
Partnership Unlocks Premium, Audience-First Advergaming Units Across the World's Largest Portfolio of CTV Games and Video Channels Partnership Unlocks Premium, Audience-First Advergaming Units Across the World's Largest Portfolio of CTV Games and Video Channels
SANTA MONICA, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games across the digital landscape, today announced the appointment of Anthony Alexander as Executive Vice President of Revenue, effective June 8, 2026.
Johnson and Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SLE.
U.S. House Trading
No House trades found for SLE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.